Merkel cell carcinoma, version 1.2014.

Christopher K. Bichakjian, Thomas Olencki, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank Glass, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Daniel D. Lydiatt, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Clifford S. Perlis, Ashok R. ShahaWade L. Thorstad, Malika Tuli, Marshall M. Urist, Timothy S. Wang, Andrew E. Werchniak, Sandra L. Wong, John A. Zic, Karin G. Hoffmann, Nicole R. McMillian, Maria Ho, comprehensive cancer network National comprehensive cancer network

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

Merkel cell carcinoma is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative nonmelanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The NCCN Guidelines for Merkel Cell Carcinoma provide recommendations on the diagnosis and management of this aggressive disease based on clinical evidence and expert consensus. This version includes revisions regarding the use of PET/CT imaging and the addition of a new section on the principles of pathology to provide guidance on the analysis, interpretation, and reporting of pathology results.

Original languageEnglish
Pages (from-to)410-424
Number of pages15
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume12
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Dive into the research topics of 'Merkel cell carcinoma, version 1.2014.'. Together they form a unique fingerprint.

Cite this